Today's Daily Dose brings you news about IMV's ovarian cancer trial results, reports of Iovance considering a possible sale, Nemaura's head -to-head study with a major Glucose Monitoring System, and disappointing trial results of Vanda and Supernus.
from RTT - Biotech https://ift.tt/2HUDgOv
via IFTTT
No comments:
Post a Comment